Certificate for COVID-19 Vaccination

Issued in India by Ministry of Health & Family Welfare, Govt. of India

Certificate ID 13949341547

Beneficiary Details
Beneficiary Name / लाभाथ का नाम Harsh Chhaunker

Age / उ 24

Gender / लग Male

ID Verified / पहचान प स ा पत Passport # V9446323

Unique Health ID (UHID) 33-1314-8760-0714

Beneficiary Reference ID 85413624222620

Vaccination Status / टीकाकरण क त Fully Vaccinated (2 Doses)

Vaccination Details
Vaccinated By / टीका लगाने वाले का नाम Divya
TATA CONSULTANCY SERVICES 01, Gautam Buddha Nagar,
Vaccination At / टीकाकरण का ान Uttar Pradesh

Dose Number Date of Dose Vaccine Name Batch Number Vaccine Type Manufacturer
खुराक क सं या खुराक क तारीख वै ीन का नाम बैच सं या टीका का कार उ पादक

COVID-19 vaccine,
1/2 27 May 2021 COVISHIELD 4121Z072 non-replicating viral vector Serum Institute of India

COVID-19 vaccine,
2/2 27 Aug 2021 COVISHIELD 4121Z108 non-replicating viral vector Serum Institute of India

“दवाई भी और कड़ाई भी।

Together, India will defeat
COVID-19”
- धानमं ी नर मोदी

In case of any adverse events, kindly contact the nearest Public Health Center/
Healthcare Worker/District Immunization Officer/State Helpline No. 1075
टीकाकरण प ात कसी तकूल घटना के होने पर नज़दीक ा क / ा कम / जला टीकाकरण
अ धकारी/रा ह लाइन 1075 पर स क कर

This certificate can be verified by scanning the QR code at

http://verify.cowin.gov.in
 Focusight Technology (Jiangsu) Co., Ltd 征图新视（江苏）科技有限公司
No.258-6,JinHua Road,WuJin Economic 常州市武进经济开发区锦华258-6
Development Zone,ChangZhou 电话：+86 0519 80583000.
Tel: +86 0519 80583000 传真：+86 0519 80583063
Fax: +86 0519 80583063

Dated 29th June 2023

Consulate General of China

Embassy of China
New Delhi, Delhi, India

Sub: Covering Letter

Dear Sir/Madam,

We Focusight Technology (Jiangsu) Co., Ltd. Would like to invite Mr. Harsh Chhaunker working as a
Contract Based Advisor (having valid Indian passport no. V9446323) to our situated at No.258-6, Jinhua
Road, Wujin Economic development District, Changzhou, Jiangsu Province, China to perform and
participate in below activities:

1. Demo and training of our Printing and Quality Inspection Machine 4 weeks training.
2. Business related activities.

We would like to inform that we Focusight Technology (Jiangsu) Co., Ltd. don’t have any registered
office/ company in India.

Kindly note, all the expenses will be borne by our company Focusight Technology (Jiangsu) Co.,
Ltd. during his stay in China including his travel expenses (international air ticket, Hotel
accommodation, Food etc.).

Thanking You,
Yours Truly,
For Focusight Technology (Jiangsu) Co. Ltd.

Gu XiangJian
Overseas Director
 Mr. HARSH CHHAUNKER-B9446323- Reference: Dr.SELF VID: 230054000369335
0767003014902 Registered On:
Client Address:
H. NO 1406,GALI NO-52/E,MOLARBAND
DELHI LAB WALKIN PATIENTS 10/07/2023 12:57 PM
EXTN BADARPUR DELHI , NEW DELHI
Tel No : 9718303197 Collected On:
Sample Processed At: Metropolis
10/07/2023 12:59PM
PIN No: 110044 Healthcare Ltd E-21, B1 Mohan Co-op
Ind Estate New Delhi-110044 Reported On:
PID NO: P542300387694
10/07/2023 06:31 PM
Age: 26.0 Year(s) Sex: Male

SARS-CoV-2 (COVID 19) Detection (Qualitative) by Real Time rt PCR

Test : Qualitative RNA detection of SARS-CoV-2 (COVID19)

Specimen Type : Nasopharyngeal swab and Oropharyngeal swab

Test principle : Real time reverse transcription PCR (ICMR approved kit)

Test description : Genes detected N, ORF1ab/ S / RdRp

Result :

SARS-COV-2 RNA Negative(NOT DETECTED)

ICMR registration no. MHLNDD

Interpretation guidelines

A. For result as “DETECTED”:

1) Detected result indicates presence of SARS-CoV-2.
2) Each “Detected” result has been verified using confirmatory test.
3) False positive is rare globally.
4) A repeat test of freshly collected specimen may give different result due to the following –
a. From appearance of symptoms, Viral load reduces day by day and one may clear virus as early
as 4.3 days¹. As viral load reduces during recovery/resolution, the result of repeat testing, even
within hours or day/s, can yield different results.
b. The new sample may have low viral load due to varied shedding of the virus.
c. Inherent variability due to improper sample collection and inadequate storage while due care is
taken at Metropolis.
5) 80% of patients with “Detected” result may be asymptomatic.
6) A detected result does not distinguish between a viable/replicating organism and a non-viable organism

B. For result as “NOT DETECTED”:

1) “Not Detected” result indicates absence of SARS-CoV-2 in the given specimen. However, it does not
rule out the infection completely and should not be used as the sole basis for making decisions related
to treatment and other patient management decisions.
2) “Not detected” result may be seen due to -
a. RT PCR done on Nasopharyngeal swab having 44% false negativity.
b. Test done too early or too late where the virus load is below detection limit.
c. Improperly collected and stored specimen.
d. Viral mutations
3) If a subsequent test is tested positive (detected), it may indicate an infection acquired subsequently or
increase in viral load to detectable level after the first test.

Dr. Abhilasha Kochhar

M.D (MICROBIOLOGY)
(DMC Reg. No. -5595)

Page 1 of 2
 Mr. HARSH CHHAUNKER-B9446323- Reference: Dr.SELF VID: 230054000369335
0767003014902 Registered On:
Client Address:
H. NO 1406,GALI NO-52/E,MOLARBAND
DELHI LAB WALKIN PATIENTS 10/07/2023 12:57 PM
EXTN BADARPUR DELHI , NEW DELHI
Tel No : 9718303197 Collected On:
Sample Processed At: Metropolis
10/07/2023 12:59PM
PIN No: 110044 Healthcare Ltd E-21, B1 Mohan Co-op
Ind Estate New Delhi-110044 Reported On:
PID NO: P542300387694
10/07/2023 06:31 PM
Age: 26.0 Year(s) Sex: Male

Disclaimers:

1. RNA viruses like SARS-CoV-2 (COVID 19) have a lot of genetic variability and it’s possible that certain virus
detection kits test cannot detect some strains of the viruses. Although efforts were made by manufacturers
of the diagnostic kits to design the test assays that target the parts of viral genome which are shared by all
the different circulating viral strains, there still might be some mismatch between the primers and the probes
used in the test and the target regions within the viruses.
2. Sensitivity of this test results depends upon the quality of the sample submitted for testing, stage of
infection, type of the specimen collected for testing, medical history and clinical presentation.
3. All approved kits being used also may have different positive and negative predictive values leading to
mismatch of results.
4. A careful consideration to combination of epidemiological factors, stage of infection, clinical history,
examination, other relevant investigation findings and treatment history should be done when interpreting
test results.
5. Current knowledge about novel coronaviruses is evolving and more studies may be required for further
evaluation and review of facts indicated in this report.

Patient Instructions:

• Kindly consult referring Physician/ Authorized Govt. hospital for appropriate follow up.
• Details of all the positive patients will be communicated to Epidemiology Cell whom you are requested to
support.
• “Detected” status needs to be notified to the appropriate authorities as per the existing rules/regulations,
while we shall also be doing the same

Clinical Background:

COVID-19 is a new disease, caused by a novel (or new) coronavirus SARS-CoV-2. Reported illnesses have
ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases. Symptoms like Fever,
Cough, and Shortness of breath may appear 2-14 days after exposure. The virus is thought to spread mainly
from person-to-person, between people who are in close contact and through respiratory droplets. It can also
spread from contact with infected surfaces or objects.

References:
1. Tao Ai et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease2019 (COVID-19) in China:
A Report of 1014 Cases

2. Yang et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and
monitoring the viral shedding of 2019-nCoV infections.

Abbreviations

ICMR : Indian Council of Medical Research

-- End of Report --

Tests marked with NABL symbol are accredited by NABL vide Certificate no MC-2676; Validity till 04-04-2024

Page 2 of 2 Dr. Abhilasha Kochhar

M.D (MICROBIOLOGY)
(DMC Reg. No. -5595)
Changzhou, 27st June 2023

To the Consulate General of China,

Embassy of the People's Republic of China in the Republic of India
50-D, Shantipath,Chanakyapuri, New Delhi-110021

Subject – Invitation Letter for Mr. Harsh Chhaunker

On behalf of Focusight Technology (Jiangsu) Co. Ltd, we would like to invite the Mr. Harsh Chhaunker to
visit our factory in Changzhou (China) in order to attend New Project - Phone Parts Quality Inspection
Machine (Machine to be Delivered in Chennai, India in May Month) and Demo of Inspection Machine at
our factory:

These meeting will be held over the period of 3 months requiring Multiple Entry Visa to China.

Travel period – 15th July 2023 to 15th August 2023

His passport generalities are as follows:

Surname – Chhaunker
Name – Harsh
Passport no. – V9446323
Gender – Male
Date of Birth: 1997-06-10
Nationality: Indian Citizen
Date of Issue – 2021/04/21
Date of Expiry – 2031/04/20

The Travel expenses including international air ticket, hotel accommodation, food, Local transportation and
other expenses related to his visit will be borne by Focusight technology (Jiangsu) Co. Ltd.

If you have any questions, please feel free to contact us at any time. Sincerely,

Focusight Technology (Jiangsu) Co., Ltd.

(Gu Xiang Jian)
Overseas Sales Director
NO.258-6, Jinhua Road, Wujin Economic Development District, Changzhou, Jiangsu Province 213145,
China
Phone - (+86) 15295166838
Email - xiangjiangu@focusight.net

Focusight Technology (Jiangsu) Co., Ltd

Address: No.258-6, Jinhua Road, Wujin District, Changzhou, R.R. China, 213145
Tel: (+86) 519 80583096 Fax: (+86) 519 80583056 website: http://en.focusight.net
Changzhou, 26th June 2023

To
The Consulate General of China,
Embassy of the People's Republic of China in the Republic of India
50-D, Shantipath, Chanakyapuri, New Delhi-110021

Subject – PURPOSE OF VISIT

Dear Sir/ Madam,

We Focusight Technology (Jiangsu) Co., Ltd. would like to invite officially Mr. Harsh Chhaunker
(holding valid Indian passport) to our factory available at No. 258-6, Jinhua Road, Wujin
Economic Development District, Changzhou, Jiangsu Province (China) to perform and participate
in below activities/training:

1. Training for a new project for Priniting Quality Inspection Machine –4 weeks (July 2023
month-August 2023).

2. Business related activities, business meetings with us to discuss about carton sorting machine
project and Demo of inspection machine at our factory.

These meetings will be held over the period of three months requiring Multiple Entry Visa to
China.

Travel Period Time: 15th July 2023 to 15th August 2023

The travel expenses including international air tickets, hotel accommodation, food, local
conveyance, and other expenses related to his visit will be borne by Focusight Technology
(Jiangsu) Co., Ltd.

Yours faithfully,

PRINT NAME: Gu Xiang Jian

TITLE: Overseas Sales Director

Focusight Technology (Jiangsu) Co., Ltd

Address: No.258-6, Jinhua Road, Wujin District, Changzhou, R.R. China, 213145
Tel: (+86) 519 80583096 Fax: (+86) 519 80583056 website: http://en.focusight.net